Suppr超能文献

用于预测或解释G蛋白偶联受体多药理学的计算研究。

Computational studies to predict or explain G protein coupled receptor polypharmacology.

作者信息

Jacobson Kenneth A, Costanzi Stefano, Paoletta Silvia

机构信息

Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-0810, USA.

Department of Chemistry and Center for Behavioral Neuroscience, American University, Washington, DC 20016, USA.

出版信息

Trends Pharmacol Sci. 2014 Dec;35(12):658-63. doi: 10.1016/j.tips.2014.10.009. Epub 2014 Nov 14.

Abstract

Since G protein-coupled receptors (GPCRs) belong to a very large superfamily of evolutionarily related receptors (>800 members in humans), and due to the rapid progress on their structural biology, they are ideal candidates for polypharmacology studies. Broad screening and bioinformatics/chemoinformatics have been applied to understanding off-target effects of GPCR ligands. It is now feasible to approach the question of GPCR polypharmacology using molecular modeling and the available X-ray GPCR structures. As an example, large and sterically constrained adenosine derivatives (potent adenosine receptor ligands with low conformational freedom and multiple extended substituents) were screened for binding at diverse receptors. Unanticipated off-target interactions, including at biogenic amine receptors, were then modeled using a structure-based approach to provide a consistent understanding of recognition. A conserved Asp in TM3 changed its role from counterion for biogenic amines to characteristic H-bonding to adenosine. The same systematic approach could potentially be applied to many GPCRs or other receptors using other sets of congeneric ligands.

摘要

由于G蛋白偶联受体(GPCRs)属于一个非常大的进化相关受体超家族(人类中有超过800个成员),并且由于其结构生物学的快速进展,它们是多药理学研究的理想候选者。广泛筛选和生物信息学/化学信息学已被用于理解GPCR配体的脱靶效应。现在,使用分子建模和可用的X射线GPCR结构来解决GPCR多药理学问题是可行的。例如,筛选了大的、空间受限的腺苷衍生物(具有低构象自由度和多个延伸取代基的强效腺苷受体配体)与多种受体的结合情况。然后使用基于结构的方法对意外的脱靶相互作用(包括与生物胺受体的相互作用)进行建模,以提供对识别的一致理解。跨膜螺旋3(TM3)中一个保守的天冬氨酸从生物胺的抗衡离子转变为与腺苷形成特征性氢键的角色。使用其他同类配体组,相同的系统方法可能潜在地应用于许多GPCR或其他受体。

相似文献

4
Chemical Diversity in the G Protein-Coupled Receptor Superfamily.G 蛋白偶联受体超家族的化学多样性。
Trends Pharmacol Sci. 2018 May;39(5):494-512. doi: 10.1016/j.tips.2018.02.004. Epub 2018 Mar 22.
6
Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.通过配体导向建模改进G蛋白偶联受体的虚拟筛选
PLoS Comput Biol. 2017 Nov 13;13(11):e1005819. doi: 10.1371/journal.pcbi.1005819. eCollection 2017 Nov.

引用本文的文献

6
Structural insights into emergent signaling modes of G protein-coupled receptors.结构视角下的 G 蛋白偶联受体新兴信号模式
J Biol Chem. 2020 Aug 14;295(33):11626-11642. doi: 10.1074/jbc.REV120.009348. Epub 2020 Jun 22.

本文引用的文献

2
Polypharmacology: challenges and opportunities in drug discovery.多药理学:药物研发中的挑战与机遇
J Med Chem. 2014 Oct 9;57(19):7874-87. doi: 10.1021/jm5006463. Epub 2014 Jun 25.
10
Polypharmacology - foe or friend?多靶标药物疗法——敌是友?
J Med Chem. 2013 Nov 27;56(22):8955-71. doi: 10.1021/jm400856t. Epub 2013 Aug 22.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验